TransMedics Group, Inc. Share Price
Equities
TMDX
US89377M1099
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.09 USD | +3.20% |
|
-3.90% | +13.51% |
| Capitalization | 457.29Cr 389.2Cr 361.46Cr 338.9Cr 631.05Cr 42TCr 669.06Cr 4.13TCr 1.64TCr 20TCr 1.71TCr 1.68TCr 72TCr | P/E ratio 2025 * |
51.5x | P/E ratio 2026 * | 48.6x |
|---|---|---|---|---|---|
| Enterprise value | 464.07Cr 394.97Cr 366.82Cr 343.92Cr 640.41Cr 43TCr 678.98Cr 4.19TCr 1.66TCr 20TCr 1.74TCr 1.7TCr 73TCr | EV / Sales 2025 * |
7.73x | EV / Sales 2026 * | 6.27x |
| Free-Float |
96.82% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: TransMedics Group, Inc.
| 1 day | +1.67% | ||
| 1 week | -3.90% | ||
| Current month | +13.51% | ||
| 1 month | +6.76% | ||
| 3 months | +15.52% | ||
| 6 months | +30.77% | ||
| Current year | +13.51% |
| 1 week | 132.02 |  | 149.22 |
| 1 month | 120.17 | | 151.85 |
| Current year | 120.17 | | 151.85 |
| 1 year | 58.54 | | 156 |
| 3 years | 36.42 | | 177.37 |
| 5 years | 10 | | 177.37 |
| 10 years | 10 | | 177.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Waleed Hassanein
CEO | Chief Executive Officer | 57 | 01/08/1998 |
| Director of Finance/CFO | 55 | 02/12/2024 | |
Nick Corcoran
COO | Chief Operating Officer | 43 | 02/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Waleed Hassanein
BRD | Director/Board Member | 57 | 01/08/1998 |
James Tobin
CHM | Chairman | 81 | 01/01/2011 |
Edward Basile
BRD | Director/Board Member | 78 | 01/02/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.50% | 0.09% | 300 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.20% | -3.90% | +122.83% | +109.04% | 457.29Cr | |
| +0.50% | +2.37% | +11.29% | +5.73% | 24TCr | |
| +0.40% | -2.87% | -13.87% | +105.41% | 19TCr | |
| -0.81% | +0.08% | -1.68% | -13.33% | 17TCr | |
| -0.46% | +1.40% | -8.99% | +99.11% | 14TCr | |
| +1.10% | -6.25% | -17.98% | -8.37% | 5.69TCr | |
| -0.82% | -0.06% | +22.31% | +5.47% | 4.94TCr | |
| -0.82% | -4.28% | -9.15% | -12.84% | 3.96TCr | |
| -1.52% | -2.05% | +3.24% | +7.96% | 3.78TCr | |
| +0.97% | -0.75% | -6.23% | +17.79% | 3.69TCr | |
| Average | +0.23% | -2.21% | +10.18% | +31.60% | 9.57TCr | |
| Weighted average by Cap. | +0.43% | -0.94% | -1.27% | +34.36% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 60Cr 51Cr 47Cr 45Cr 83Cr 5.5TCr 88Cr 541.99Cr 214.77Cr 2.6TCr 225.21Cr 220.59Cr 9.51TCr | 73Cr 62Cr 57Cr 54Cr 100.06Cr 6.64TCr 106.09Cr 654.37Cr 259.3Cr 3.14TCr 271.9Cr 266.33Cr 11TCr |
| Net income | 10Cr 8.59Cr 7.97Cr 7.48Cr 14Cr 923.89Cr 15Cr 91Cr 36Cr 436.42Cr 38Cr 37Cr 1.6TCr | 11Cr 9.26Cr 8.6Cr 8.06Cr 15Cr 996.67Cr 16Cr 98Cr 39Cr 470.8Cr 41Cr 40Cr 1.72TCr |
| Net Debt | 6.78Cr 5.77Cr 5.36Cr 5.03Cr 9.36Cr 621.31Cr 9.92Cr 61Cr 24Cr 293.49Cr 25Cr 25Cr 1.07TCr | -2.67Cr -2.27Cr -2.11Cr -1.98Cr -3.68Cr -244.53Cr -3.91Cr -24Cr -9.55Cr -115.51Cr -10Cr -9.81Cr -422.69Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | 138.09 $ | +3.20% | 8,57,570 |
| 21/26/21 | 133.81 $ | -5.72% | 11,48,804 |
| 20/26/20 | 141.93 $ | -1.00% | 8,19,356 |
| 16/26/16 | 143.37 $ | -0.22% | 8,19,225 |
| 15/26/15 | 143.69 $ | +1.22% | 5,42,114 |
Delayed Quote Nasdaq, January 23, 2026 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TMDX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition